Etrasimod

Short Description:

API’s Name CAS No. US DMF Patent Expiry Date (US) Current status
Etrasimod  1206123-37-6  Jun, 2026  Mar.05, 2030 PV Completion

 

[Indication] 

  • Ulcerative colitis (UC): For the treatment of moderately to severely active ulcerative colitis (UC) in adults.


Product Detail

Product Tags


  • Previous:
  • Next:

  • Write your message here and send it to us